share_log

Barclays Maintains Overweight on Viatris, Raises Price Target to $16

Benzinga ·  Feb 28, 2023 09:30

Barclays analyst Balaji Prasad maintains Viatris (NASDAQ:VTRS) with a Overweight and raises the price target from $15 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment